Henry Perez
Family · Riverview, FLNPI 1477225365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $437, 4.0 times the $109 reported in 2022.
Across 65 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$219
- AstraZeneca$139
- Lilly USA, LLC$110
- Teva Pharmaceuticals USA, Inc.$109
- Shield Therapeutics Inc$101
- AbbVie$88
- plus $498 from 14 others
What the payments were for
- Food & beverage$1,264100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 11 | $219 |
| AstraZeneca | 9 | $139 |
| Lilly USA, LLC | 6 | $110 |
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| Shield Therapeutics Inc | 5 | $101 |
| AbbVie | 5 | $88 |
| Exact Sciences | 4 | $85 |
| Astellas Pharma US Inc | 3 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Novo Nordisk | 2 | $47 |
| Amgen | 2 | $32 |
| Bayer | 1 | $27 |
| Amarin Pharma, Inc. | 1 | $20 |
| GSK | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
How this compares
$1,264 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 13 | $184 |
| Tramadol Hcl | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other family in Riverview
- Ashley WheelerRiverview$45K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.